Searched for
OTX 101
Sun Pharma climbs 2% on USFDA approvalThe drug in question is CEQUA (cyclosporine ophthalmic solution) 0.09 per cent.- Sun Pharma reports 75% fall in net profit on tepid sales in USSun Pharmaceutical Industries on Wednesday reported net profit of Rs 365 crore for the third quarter.
- ETMarkets After Hours: RCom rally on; DLF slips post GIC dealShares of Reliance Communications extended their rally into the second straight session.
- Market comes off lifetime high; Sensex falls 99 pts, Nifty below 10,500In the commodity space, gold prices regained the Rs 30,000-level with a jump of Rs 100.
- Sun Pharma climbs 3% after USFDA accepts new drug applicationhares of the company opened at Rs 545 and touched a high and low of Rs 559.30 and Rs 543.15, respectively, in trade so far.
- USFDA accepts Sun Pharma arm's ophthalmic drug applicationSun Pharma said that post the USFDA approval, OTX-101 will be commercialised in the US by Sun Ophthalmics, the branded ophthalmics division...
Load More